Rafols, Loisie Love L.
HRN: 26-71-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2025
CEFUROXIME 1.5GM (VIAL)
05/21/2025
05/22/2025
IV
1.5g
Q8h X3doses
Sp Cs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes